Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 30, 2020
Operant self-stimulation of thalamic terminals in the dorsomedial striatum is constrained by metabotropic glutamate receptor 2Kari A Johnson, Lucas Voyvodic, Gabriel C Loewinger, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 11, 2005
Reduced dopamine terminal function and insensitivity to cocaine following cocaine binge self-administration and deprivationYolanda Mateo, Christopher M Lack, Drake Morgan, et al.
The European Journal of Neuroscience|November 19, 2004
Fast onset of dopamine uptake inhibition by intravenous cocaineYolanda Mateo, Evgeny A Budygin, Drake Morgan, et al.
The European Journal of Neuroscience|November 19, 2013
Chronic methylphenidate exposure during adolescence reduces striatal synaptic responses to ethanolNicole A Crowley, Patrick A Cody, Margaret I Davis, et al.
Nature Reviews. Neuroscience|March 1, 2022
Local modulation by presynaptic receptors controls neuronal communication and behaviourDavid M Lovinger, Yolanda Mateo, Kari A Johnson, et al.
The European Journal of Neuroscience|September 16, 2018
Contributions of nucleus accumbens dopamine to cognitive flexibilityAnna K Radke, Adrina Kocharian, Dan P Covey, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 8, 2012
Cocaine self-administration produces pharmacodynamic tolerance: differential effects on the potency of dopamine transporter blockers, releasers, and methylphenidateMark J Ferris, Erin S Calipari, Yolanda Mateo, et al.
International Journal of Molecular Sciences|October 14, 2022
Chronic Ethanol Consumption Alters Presynaptic Regulation of Dorsal Striatal Dopamine Release in C57BL/6J MiceArmando G Salinas, Jacob A Nadel, Yolanda Mateo, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 22, 2018
Inhibition of endocannabinoid degradation rectifies motivational and dopaminergic deficits in the Q175 mouse model of Huntington's diseaseDan P Covey, Hannah M Dantrassy, Samantha E Yohn, et al.
Pageof 4